The need for a critical review of the intellectual property system and incentives for medical innovation (June 2016)

Brussels, 2 June 2016
25 Civil Society organisations, including the Medicines in Europe Forum and the International Society of Drug Bulletins, call on Member States to resist pressure from the pharmaceutical industry to eliminate critical elements of proposed European Union (EU) Council Conclusions that would improve the balance between innovation and patients’ access to affordable medicines.

> Click here to download the Joint Statement (pdf, 122 Ko)